Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Adv Healthc Mater ; 11(18): e2201679, 2022 09.
Article in English | MEDLINE | ID: mdl-36026579

ABSTRACT

Guided bone regeneration (GBR) therapy demonstrates a prominent curative effect on the management of craniomaxillofacial (CMF) bone defects. In this study, a GBR membrane consisting of a microporous layer and a struvite-nanowire-doped fibrous layer is constructed via non-solvent induced phase separation, followed by an electrospinning procedure to treat critical-sized calvarial defects. The microporous layer shows selective permeability for excluding the rapid-growing non-osteogenic tissues and potential wound stabilization. The nanowire-like struvite is synthesized as the deliverable therapeutic agent within the fibrous layer to facilitate bone regeneration. Such a membrane displays a well-developed heterogeneous architecture, satisfactory mechanical performance, and long-lasting characteristics. The in vitro biological evaluation reveals that apart from being a strong barrier, the bilayer struvite-laden membrane can actively promote cellular adhesion, proliferation, and osteogenic differentiation. Consequently, the multifunctional struvite-doped membranes are applied to treat 5 mm-sized bilateral calvarial defects in rats, resulting in overall improved healing outcomes compared with the untreated or the struvite-free membrane-treated group, which is characterized by enhanced osteogenesis and significantly increased new bone formation. The encouraging preclinical results reveal the great potential of the bilayer struvite-doped membrane as a clinical GBR device for augmenting large-area CMF bone reconstruction.


Subject(s)
Nanowires , Osteogenesis , Animals , Biocompatible Materials/pharmacology , Bone Regeneration , Membranes, Artificial , Rats , Struvite/pharmacology
2.
Biomed Tech (Berl) ; 65(5): 631-641, 2020 Oct 25.
Article in English | MEDLINE | ID: mdl-32452822

ABSTRACT

To develop implants with improved bone ingrowth, titanium substrates were coated with homogeneous and dense struvite (MgNH4PO4·6H2O) layers by means of electrochemically assisted deposition. Strontium nitrate was added to the coating electrolyte in various concentrations, in order to fabricate Sr-doped struvite coatings with Sr loading ranging from 10.6 to 115 µg/cm2. It was expected and observed that osteoclast activity surrounding the implant was inhibited. The cytocompatibility of the coatings and the effect of Sr-ions in different concentrations on osteoclast formation were analyzed in vitro. Osteoclast differentiation was elucidated on morphological, biochemical as well as on gene expression level. It could be shown that moderate concentrations of Sr2+ had an inhibitory effect on osteoclast formation, while the growth of osteoblastic cells was not negatively influenced compared to pure struvite surfaces. In summary, the electrochemically deposited Sr-doped struvite coatings are a promising approach to improve bone implant ingrowth.


Subject(s)
Nitrates/pharmacology , Osteoblasts/cytology , Strontium/pharmacology , Struvite/pharmacology , Titanium/pharmacology , Animals , Bone and Bones/physiology , Nitrates/chemistry , Prostheses and Implants , Strontium/chemistry , Struvite/chemistry , Titanium/chemistry
3.
Chemosphere ; 182: 48-53, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28486155

ABSTRACT

Hexavalent chromium species (Cr(VI)) are often carcinogenic, of high acute toxicity, highly mobile, and thus pose a severe risk to health and environment. Fertilizers usually contain significant amounts of chromium. Therefore, a reliable analysis of chromium and the fraction of Cr(VI) are crucial for safe use of fertilizers. This problem is expected to increase in the future, since more and more recycled fertilizers emerge due to increasing fertilizer demand and respective supply risks. However, existing analytical methods have been developed for conventional fertilizers and have to be tested whether they are suitable for the new materials. Thus, we performed a wet-chemical extraction for Cr(VI) on several matrices as well as respective quality control experiments including spiking with Cr(III) and Cr(VI) compounds. We found the Cr(VI) amounts to be below 2 mg/kg except for a thermally post-treated sewage sludge ash (SSA) that showed 12.3 mg/kg. The presence of organic matter e.g. in sludge or precipitated struvite caused a reduction of spiked Cr(VI) and thus no satisfying recovery for quality control. Cr(VI) reduction was also observed for SSA, presumably due to the presence of Fe(II) compounds. Even though the tested procedure can be hampered in some recycled fertilizer matrices, it might be adapted to be applicable also for these complex samples.


Subject(s)
Chromium/analysis , Fertilizers/analysis , Chromium/chemistry , Quality Control , Sewage/chemistry , Struvite/pharmacology
4.
Mater Sci Eng C Mater Biol Appl ; 73: 111-119, 2017 Apr 01.
Article in English | MEDLINE | ID: mdl-28183587

ABSTRACT

Bioceramic degradation can occur by both passive dissolution and following active osteoclastic bone remodeling. Key parameters controlling ceramic degradation are the pH-dependent solubility product of the ceramic phase, which alters ion concentrations in physiological solution and hence regulates cell activity. This study investigated the in vitro degradation profiles of various calcium magnesium phosphate ceramics formed at low temperature. The passive resorption was measured by incubating the cement samples in cell culture medium, while active resorption was determined during a surface culture of multinuclear osteoclastic cells derived from RAW 264.7 macrophages. All surfaces showed mostly similar TRAP activities after adding RANKL-factor to stimulate osteoclastogenesis. The active degradation of the materials by osteoclasts was found to be the predominant factor for ceramic dissolution as determined by measuring the ion concentrations of cell culture medium. Here, large sized osteoclasts formed predominantly on ceramics with a Mg:Ca ratio ≥2.0 seemed to be less effective compared to smaller macrophages.


Subject(s)
Bone Cements/pharmacology , Bone Resorption/pathology , Calcium/analysis , Magnesium/analysis , Osteoclasts/pathology , Struvite/pharmacology , Actins/metabolism , Animals , Cell Count , Cell Death/drug effects , Cell Nucleus/metabolism , Cell Shape/drug effects , Cell Size/drug effects , Compressive Strength , Durapatite/pharmacology , Fluorescent Antibody Technique , Ions , Mice , Osteoclasts/drug effects , Osteoclasts/ultrastructure , Porosity , RAW 264.7 Cells , Spectrophotometry, Atomic , Staining and Labeling , Tartrate-Resistant Acid Phosphatase/metabolism , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL